Physician profile
Deborah Ann Elder
NPI 1306927454
$2,197.67
in general payments reported to CMS, 2019-2025
15 companies · $662 in 2025
The $662 reported for 2025 was more than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $95.43 · 2022: $263 · 2023: $279 · 2024: $555 · 2025: $662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,496.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $365.54 | 2019-2022 | |
| Medtronic, INC. | $298.29 | 2024-2025 | Minimed 780g |
| Beta Bionics, INC. | $277.35 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Tandem Diabetes Care, INC. | $219.34 | 2020-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Sanofi-Aventis U.S. LLC | $142.25 | 2025 | |
| Abbott Laboratories | $140.72 | 2022 | |
| Novo Nordisk INC | $123.31 | 2019 | |
| Ascendis Pharma Endocrinology INC | $121.04 | 2024 | |
| Mannkind Corporation | $117.72 | 2025 | |
| Pfizer INC. | $115.67 | 2023 | |
| Dexcom, INC. | $94.48 | 2023 | Dexcom G7 Gss (161) |
| Sequel Med Tech, LLC | $93.93 | 2025 | Twiist |
| Biomarin Pharmaceutical INC. | $69.09 | 2023 | Voxzogo 1.2mg |
| Kyowa Kirin, INC. | $18.94 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Elder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.